Official data from INPI

122022023844

Em ExigênciaUtility ModelPCT · EP2018060868

Talk to an expert

Application data

Number

122022023844

Type

Utility Model

Filing

04/27/2018

Publication

PCT

EP2018060868

View on INPI

Progress at the INPI

Office action pending

Filing04/27/18
Publication
Examination
Allowance
Grant
In force

The INPI issued a technical office action on this application. If it is not answered in time, the application is abandoned (art. 36 of the Brazilian IP Act).

Latest action published by the INPI: 03/03/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PHARMA MAR, S.A.

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Exigência - art. 36 da LPI

#6.1

03/03/2026

RPI 2878

Notificação de pedido dividido

#2.4

01/10/2023

RPI 2714

Requerimento de pedido de patente

#2.10

Número de Protocolo '870220108510' em 23/11/2022 13:41 (WB)

12/06/2022

RPI 2709

From the same holder

112026012709 COMBINAÇÃO DE LURBINECTEDINA E DOXORRUBICINA COMBINAÇÕES DE LURBINECTEDINA E ATEZOLIZUMABE REGIMES DE DOSAGEM PARA ECUBECTEDINA COMBINAÇÕES DE LURBINECTEDINA E INIBIDOR DE PONTO DE VERIFICAÇÃO IMUNOLÓGICO CONJUGADOS DE FÁRMACO E ANTICORPO COMPOSTOS PARA USO EM CONDIÇÕES AUTOIMUNES COMPOSTOS PARA USO NO TRATAMENTO DE INFECÇÃO POR CORONAVÍRUS

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.